Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk
Open Access
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 13 (4), 349-355
- https://doi.org/10.1097/gim.0b013e3182091ba4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 MutationsObstetrics & Gynecology, 2010
- Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon CancerJournal of Clinical Oncology, 2009
- Guidelines for Genetic Risk Assessment of Hereditary Breast and Ovarian Cancer: Early Disagreements and Low UtilizationJournal of General Internal Medicine, 2009
- BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancerCancer, 2009
- Differential use of available genetic tests among primary care physicians in the United States: results of a national surveyGenetics in Medicine, 2008
- Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control StudyJournal of Clinical Oncology, 2005
- Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2004
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Interest in BRCA1/2 Testing in a Primary Care PopulationPreventive Medicine, 2002
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999